39
Views
5
CrossRef citations to date
0
Altmetric
Review

Cancer mucosa antigens: novel immunotherapeutic targets

&
Pages 749-756 | Published online: 15 May 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Liu Hong, Shujun Li, Yu Han, Jianjun Du, Hongwei Zhang, Jipeng Li, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2011) Angiogenesis-related molecular targets in esophageal cancer. Expert Opinion on Investigational Drugs 20:5, pages 637-644.
Read now
Liu Hong, Yu Han, Shujun Li, Jianjun Yang, Jianyong Zheng, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2010) The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas. Expert Opinion on Biological Therapy 10:12, pages 1693-1701.
Read now

Articles from other publishers (3)

Zheng ChenLiu HongLin LiuDaorong PengQuanjiang LiBin JinTaidong QiaoKaichun WuDaiming Fan. (2010) Monoclonal Antibody MG7 as a Screening Tool for Gastric Cancer. Hybridoma 29:1, pages 27-30.
Crossref
Genlin Ji. (2009) A Novel Monoclonal Antibody Specific to Peptide pdnaelvlltlgqawqg. Hybridoma 28:5, pages 373-376.
Crossref
Mengbin LiHongwei ZhangLiu HongYan JinTaiqian GongLi SunJianjun YangXiushan Zheng. (2009) Preparation and Characterization of a Novel Monoclonal Antibody Specific to Human CAD Protein. Hybridoma 28:2, pages 129-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.